| Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015-2018 RD Shearer, BA Howell, G Bart, TNA Winkelman Drug and alcohol dependence 214, 108162, 2020 | 78 | 2020 |
| Impact of the COVID-19 pandemic on HIV testing rates across four geographically diverse urban centres in the United States: an observational study E Moitra, J Tao, J Olsen, RD Shearer, BR Wood, AM Busch, A LaPlante, ... The LANCET Regional Health–Americas 7, 2022 | 49 | 2022 |
| Manganese(III) porphyrins complexed with P22 virus-like particles as T 1-enhanced contrast agents for magnetic resonance imaging S Qazi, M Uchida, R Usselman, R Shearer, E Edwards, T Douglas JBIC Journal of Biological Inorganic Chemistry 19, 237-246, 2014 | 36 | 2014 |
| Associations between polysubstance use patterns and receipt of medications for opioid use disorder among adults in treatment for opioid use disorder BR Ford, G Bart, B Grahan, RD Shearer, TNA Winkelman Journal of addiction medicine 15 (2), 159-162, 2021 | 22 | 2021 |
| Characterizing trends in methamphetamine-related health care use when there is no ICD code for “methamphetamine use disorder” RD Shearer, ND Shippee, TNA Winkelman Journal of substance abuse treatment 127, 108369, 2021 | 13 | 2021 |
| COVID-19 Vaccination Of People Experiencing Homelessness And Incarceration In Minnesota: Study examines COVID-19 vaccination of people experiencing homelessness and … RD Shearer, KD Vickery, P Bodurtha, PE Drawz, S Johnson, J Jeruzal, ... Health Affairs 41 (6), 846-852, 2022 | 11 | 2022 |
| Opioid and stimulant attributed treatment admissions and fatal overdoses: using national surveillance data to examine the intersection of race, sex, and polysubstance use, 1992 … AA Jones, RD Shearer, JE Segel, A Santos-Lozada, S Strong-Jones, ... Drug and alcohol dependence 249, 109946, 2023 | 7 | 2023 |
| Patient characteristics and subsequent health care use by location of SARS-CoV-2 testing initiation in a safety-net health system R Khazanchi, TNA Winkelman, D Pandita, R Jelinek, RD Shearer, ... JAMA Network Open 4 (6), e2112857-e2112857, 2021 | 7 | 2021 |
| Associations between prescription and illicit stimulant and opioid use in the United States, 2015–2020 RD Shearer, A Jones, BA Howell, JE Segel, TNA Winkelman Journal of substance abuse treatment 143, 108894, 2022 | 6 | 2022 |
| Trends in substance use disorder-related admissions at a safety-net hospital, 2008–2020 AR Lindsay, RD Shearer, G Bart, TNA Winkelman Journal of addiction medicine 16 (3), 360-363, 2022 | 5 | 2022 |
| Rethinking the use of “polysubstance” to describe complex substance use patterns RD Shearer, G Bart, C Reznikoff Journal of general internal medicine 37 (12), 3174-3175, 2022 | 4 | 2022 |
| A longitudinal cross-sectional analysis of substance use treatment trends for individuals experiencing homelessness, criminal justice involvement, both, or neither-United … RD Shearer, ND Shippee, KD Vickery, MA Stevens, TNA Winkelman The Lancet Regional Health–Americas 7, 2022 | 4 | 2022 |
| Hospital addiction medicine consultation service orders and outcomes by patient race and ethnicity in an urban, safety-net hospital AR Lindsay, TNA Winkelman, G Bart, MT Rhodes, RD Shearer Journal of general internal medicine 39 (2), 168-175, 2024 | 2 | 2024 |
| Understanding Regional Patterns of Overdose Deaths Related to Opioids and Psychostimulants JE Segel, RD Shearer, AA Jones, UG Khatri, BA Howell, DM Crowley, ... Substance Use & Misuse 59 (4), 558-566, 2024 | 1 | 2024 |
| Are you thinking what I’m thinking? Defining what we mean by “polysubstance use.” AM Bunting, R Shearer, AN Linden-Carmichael, AR Williams, SD Comer, ... The American Journal of Drug and Alcohol Abuse 50 (1), 1-7, 2024 | 1 | 2024 |
| State level variation in substance use treatment admissions among criminal legal-referred individuals RD Shearer, TNA Winkelman, UG Khatri Drug and alcohol dependence 240, 109651, 2022 | 1 | 2022 |
| X-Waiver exemption in the treatment of opioid use disorder RD Shearer, BR Ford, BA Howell JAMA 326 (5), 441-442, 2021 | 1 | 2021 |
| Racial and Ethnic Differences in Heroin, Methamphetamine, and Cocaine Use, Treatment, and Mortality Trends in 3 National Data Sources—United States, 2010-2019 RD Shearer, JE Segel, BA Howell, AA Jones, UG Khatri, DT da Silva, ... Medical Care 62 (3), 151-160, 2024 | | 2024 |
| Characteristics and co-morbidities associated with hospital discharges for opioid and methamphetamine co-use, United States 2016-2019 RD Shearer, ND Shippee, BA Virnig, TJ Beebe, TNA Winkelman Drug and Alcohol Dependence Reports, 100219, 2024 | | 2024 |
| Providers’ Experiences and Perspectives in Treating Patients With Co-Occurring Opioid and Stimulant Use Disorders in the Hospital RD Shearer, E Hernandez, TJ Beebe, BA Virnig, G Bart, TNA Winkelman, ... Substance Use & Addiction Journal, 29767342231221060, 2024 | | 2024 |
